Compare AstraZeneca plc (AZN) vs NetEase Inc (NTES) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs NetEase Inc — how do they compare? AstraZeneca plc trades at $165.31 (market cap $258.17B), while NetEase Inc trades at $129.7 (market cap $84.51B). The key difference: AstraZeneca plc is far larger — about 3.1× NetEase Inc's market cap, and NetEase Inc pays the higher dividend (2.3%). Which is the better fit depends on your goals.
| AZN | NTES | |
|---|---|---|
Market Cap | $258.17B | $84.51B |
Sector | Health | Media |
52-Week High | $209.48 | $159.34 |
52-Week Low | $137.44 | $109.26 |
Enterprise Value | $284.41B | $60.98B |
Dividend Yield | 1.87% | 2.3% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About NetEase Inc
NetEase, which started on an internet portal service in 1997, is a leading online services provider in China. Its key services include online/mobile games, cloud music, media, advertising, email, live streaming, online education, and e-commerce. The company develops and operates some of the China's most popular PC client and mobile games, and it partners with global leading game developers, such as Blizzard Entertainment and Mojang (a Microsoft subsidiary).
Read more on NTES →
